I completely agree Sanchez. You mention only the syringe which has huge prospects. Braun has estimated income in Australia alone over next 5 years somewhere around 10 - 12 million for SCALPAL alone, with sales all over the world on top of this.
Don'[t be fooled by low volume over last day or 2 - It just shows that there is B**** A** selling in this consolidation phase.
Buying will return with avengence. With shares in escrow only 25 million in total - I think we do have another cochlier at least.
Technically I really can't see it closing below 2.76
- Forums
- ASX - By Stock
- OVT
- OMI - Lovely!
OMI - Lovely!, page-7
Featured News
Add OVT (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $45.85M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
OVT (ASX) Chart |
Day chart unavailable
The Watchlist
BGD
BARTON GOLD HOLDINGS LIMITED
Alex Scanlon, Managing Director & CEO
Alex Scanlon
Managing Director & CEO
SPONSORED BY The Market Online